Spectrum Pharmaceuticals, Inc.
157 Technology Drive
Irvine,
CA 92618
United States - Map
Phone: 949-788-6700
Fax: 949-788-6706
Web Site: http://www.sppirx.com
| Spectrum Pharmaceuticals, Inc. operates as a commercial-stage biotechnology company with a primary focus in oncology market. The company focuses on acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products. Its marketed products include ZEVALIN, a form of cancer therapy called radioimmunotherapy for the treatment of non-Hodgkin's Lymphoma; and FUSILEV, which is indicated after high-dose methotrexate therapy in patients with osteosarcoma. The company also develops apaziquone for the treatment of non-muscle invasive bladder cancer. Its phase II products comprise Ozarelix, a drug being investigated for benign prostatic hypertrophy, a non-cancerous enlargement of the prostate; and Ortataxel, a third-generation taxane. In addition, Spectrum Pharmaceuticals, Inc. has exclusive worldwide rights to Renazorb, Renalan, and related compounds. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is based in Irvine, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Rajesh C. Shrotriya M.D., 64
Chairman, Chief Exec. Officer, Pres, Chairman of Placement Committee and Chairman of Product Acquisition Committee |
$
1.60M |
$
401.00K | Mr. Shyam K. Kumaria C.P.A., M.B.A., 59
Principal Financial Officer, Principal Accounting Officer, VP of Fin. and Sec. |
N/A
| N/A | Mr. William Pedranti Esq.,
VP and Gen. Counsel |
N/A
| N/A | Dr. Andrew Sandler M.D.,
Chief Medical Officer |
N/A
| N/A | Dr. Michael Adam Ph.D., 51
Sr. VP of Pharmaceutical Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.03% Nasdaq 
Profile
